Asymmetry Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $15.7M | Buy |
+177,741
| New | +$15.7M | 8.34% | 1 |
|
|
2021
Q1 | – | Sell |
-88,195
| Closed | -$7.73M | – | 30 |
|
|
2020
Q4 | $7.73M | Buy |
+88,195
| New | +$7.73M | 3.53% | 12 |
|
|
2020
Q2 | – | Sell |
-54,676
| Closed | -$4.62M | – | 34 |
|
|
2020
Q1 | $4.62M | Buy |
54,676
+20,895
| +62% | +$1.77M | 5.05% | 5 |
|
|
2019
Q4 | $2.86M | Sell |
33,781
-15,481
| -31% | -$1.31M | 5.12% | 2 |
|
|
2019
Q3 | $3.32M | Sell |
49,262
-127,063
| -72% | -$8.56M | 7.12% | 6 |
|
|
2019
Q2 | $15.1M | Buy |
+176,325
| New | +$15.1M | 8.18% | 3 |
|
|
2018
Q1 | – | Sell |
-10,733
| Closed | -$957K | – | 37 |
|
|
2017
Q4 | $957K | Buy |
+10,733
| New | +$957K | 1.3% | 22 |
|